Добавить новость
ru24.net
News in English
Апрель
2020

Новости за 11.04.2020

Hydroxychloroquine should be used as prophylaxis, not as treatment for COVID-19: ICMR

Business Standard 

The Indian Council of Medical Research (ICMR) on Saturday said that hydroxychloroquine or HCQ should be used as prophylaxis to prevent the coronavirus and not as a treatment for COVID-19."Two trials were conducted aborad. The trails were not good enough. So, we thought if it needs to used in our country, it should be used as prophylaxis, and not as a treatment," Raman R Ganagakhedkar, Head Scientist, ICMR, told ANI."We have decided that if it reduces the chances of COVID-19 among doctors and their contacts, then we will advise it to others. Читать дальше...

Himachal Pradesh reports 2 new coronavirus cases, total 32

Business Standard 

Two new positive COVID-19 cases have been reported in Himachal Pradesh on Wednesday, taking the total cases to 32 in the State, said RD Dhiman Additional chief Secretary (ACS), Department of Health and Family Welfare."954 samples have been tested so far and 2969 people have completed 28 days of quarantine," said Dhiman in a statement.Meanwhile, the total number of COVID-19 positive cases stand at 7,529 including 6634 active cases, said Ministry of Health and Family Welfare on Saturday.So far 652... Читать дальше...



Watch What Scientists Believe Is Longest-Ever Organism

Sputnik International 

Siphonophores are marine organisms that are actually gelatinous strings that can grow to 100 feet long. According to the Monterey Bay Aquarium Research Institute, siphonophores feed on tiny fish and copepods, and even other siphonophores.

Vogue Italia

MODELS.com 

Reduced Circumstances More...

Napout denied compassionate prison release

NBCSports.com 

A federal judge denied a request by the former head of CONMEBOL to be given compassionate release from prison because of the coronavirus pandemic.

Новости России
Москва

Знаменитый ультрамарафонец Максим Егоров пробежит 42,2 км в поддержку фонда «Жизнь в Движении»


Two-Thirds of COVID-19 Patients Improve After Remdesivir

Real Clear Science 

Deena Beasley, Reut
More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc. (GILD.O), according to new data based on patient observation.


Спорт в России и мире

Новости спорта


Новости тенниса
Андрей Рублёв

Теннисист Алькарас назвал Рублева одним из самых сильных игроков в туре






"Ъ": Авиаколлапс 5–6 июля может обойтись авиакомпаниям в 20 млрд руб

В МИД России рассказали о росте в Европе числа сторонников диалога с РФ

"Гранд Сервис Экспресс" добавил вагоны из-за задержек рейсов в Москве

РИА Новости: число заявлений о рождении детей в 2025 году превысило миллион